Crossmark Global Holdings Inc. Purchases 6,367 Shares of Stryker Corporation $SYK

Crossmark Global Holdings Inc. lifted its position in shares of Stryker Corporation (NYSE:SYK) by 31.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,820 shares of the medical technology company’s stock after acquiring an additional 6,367 shares during the period. Crossmark Global Holdings Inc.’s holdings in Stryker were worth $9,426,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Ethic Inc. lifted its stake in Stryker by 5.4% in the 4th quarter. Ethic Inc. now owns 53,906 shares of the medical technology company’s stock valued at $18,946,000 after purchasing an additional 2,781 shares during the last quarter. Patten & Patten Inc. TN bought a new position in Stryker in the 4th quarter valued at approximately $254,000. Chesapeake Wealth Management increased its position in Stryker by 3.0% in the 4th quarter. Chesapeake Wealth Management now owns 1,357 shares of the medical technology company’s stock valued at $477,000 after acquiring an additional 40 shares during the period. Strategic Wealth Advisors LLC acquired a new position in Stryker in the 4th quarter valued at approximately $69,000. Finally, CGC Financial Services LLC acquired a new position in Stryker in the 4th quarter valued at approximately $29,000. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Jefferies Financial Group restated a “buy” rating and issued a $465.00 price target on shares of Stryker in a research report on Wednesday, March 4th. Sanford C. Bernstein set a $410.00 price target on shares of Stryker in a research report on Friday, May 1st. Wells Fargo & Company decreased their price target on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Citigroup decreased their price target on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. Finally, William Blair restated an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $395.48.

Stryker Stock Down 3.0%

Shares of NYSE:SYK opened at $285.49 on Friday. The business’s 50 day simple moving average is $340.37 and its two-hundred day simple moving average is $355.17. The firm has a market cap of $109.34 billion, a P/E ratio of 33.04, a PEG ratio of 1.80 and a beta of 0.80. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. Stryker Corporation has a 52-week low of $284.95 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. During the same period last year, the business posted $2.84 earnings per share. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts forecast that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.